Ref (type) | Population | Outcome, Interventions | Results and statistical analysis | Effect size | Favours |
Adverse effects | |||||
RCT |
76 people with tinnitus considered to be at high risk of developing severe and disabling tinnitus |
Adverse effects
16 weeks
with sertraline (25 mg/day for 1 week followed by 50 mg/day for 15 weeks) with placebo |
The RCT may have been underpowered to detect a clinically meaningful difference between groups |